Ibuprofeno Tolife (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which reduces the synthesis of prostaglandins. Lower prostaglandin levels decrease peripheral pain signalling, lower the hypothalamic temperature set‑point, and limit the inflammatory response.

The appropriate dose of Ibuprofeno Tolife is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response. Typical adult regimens range from 200 mg to 400 mg every 4‑6 hours, not exceeding the maximum daily limit, but exact dosing must follow the prescriber’s order.

Safety data for ibuprofen in pregnancy are limited. It is generally avoided, especially in the third trimester, due to potential fetal cardiovascular effects. During breastfeeding, small amounts may pass into milk; caution is advised. Patients should consult their obstetrician or pediatrician before use.

To order Ibuprofeno Tolife, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements), and necessary import documentation.

Ibuprofeno Tolife offers a well‑established balance of analgesic, antipyretic, and anti‑inflammatory activity similar to other non‑selective NSAIDs such as naproxen or diclofenac. Its safety profile, particularly gastrointestinal and renal considerations, is comparable, while individual patient tolerance and specific drug‑interaction profiles may guide selection among agents.

Store Ibuprofeno Tolife at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, excessive heat, and direct sunlight to maintain potency throughout the shelf life.

Ibuprofeno Tolife is taken orally. Swallow the tablet whole with a full glass of water. It may be taken with or without food; taking it with food can reduce gastrointestinal discomfort in some patients.

Serious risks include gastrointestinal bleeding or ulcer perforation, acute renal failure, cardiovascular events such as myocardial infarction or stroke, and severe hypersensitivity reactions like anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored for these events, especially when used at high doses or for prolonged periods.

Ibuprofeno Tolife should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe renal or hepatic impairment, uncontrolled heart failure, and in the third trimester of pregnancy. Pediatric use should follow age‑specific guidelines provided by a healthcare professional.